Effect of ICRF 159 on immune responses.
作者信息
Hellmann K
出版信息
Proc R Soc Med. 1972 Mar;65(3):264-5. doi: 10.1177/003591577206500317.
Abstract
摘要
相似文献
1
Effect of ICRF 159 on immune responses.ICRF 159对免疫反应的影响。
Proc R Soc Med. 1972 Mar;65(3):264-5. doi: 10.1177/003591577206500317.
2
Significance of chemical carcinogen-induced immunosuppression in mammary tumorigenesis in BALB-c mice.化学致癌物诱导的免疫抑制在BALB-c小鼠乳腺肿瘤发生中的意义
Cancer Res. 1974 Oct;34(10):2663-8.
3
Immunosuppression by bisdioxopiperazines: effects on antibody-forming cells and serum titers.双二氧哌嗪的免疫抑制作用：对抗体形成细胞和血清滴度的影响。
J Natl Cancer Inst. 1972 May;48(5):1347-54.
4
Selective alteration of immunocompetence with methotrexate and 5-fluorouracil.甲氨蝶呤和5-氟尿嘧啶对免疫能力的选择性改变。
Cancer Res. 1974 Jan;34(1):124-8.
5
Selective immunosuppression by drugs in balanced immune responses.药物在平衡免疫反应中的选择性免疫抑制作用。
Fed Proc. 1974 Aug;33(8):1882-5.
6
Immunosuppression by the bisdioxopiperazines ICRF 154 and 159.
Biomedicine. 1973 May;18(3):199-205.
7
8
The effect of polyinosinic-polycytidylic acid on the immune response of mice to antigenically distinct tumors.聚肌苷酸-聚胞苷酸对小鼠针对抗原性不同肿瘤的免疫反应的影响。
Cancer Res. 1972 May;32(5):889-92.
9
Basic proteins and synthetic polynucleotides as modifiers of immunogenicity of syngeneic tumor cells.作为同基因肿瘤细胞免疫原性调节剂的碱性蛋白质和合成多核苷酸
Isr J Med Sci. 1971 Jan;7(1):72-82.
10
Inhibition of tumor growth with a new synthetic ribonucleic acid.一种新型合成核糖核酸对肿瘤生长的抑制作用
Surg Forum. 1970;21:122-4.
引用本文的文献
1
2
Factors in tumour dissemination.肿瘤播散的因素。
Proc R Soc Med. 1974 Sep;67(9):847-9. doi: 10.1177/003591577406700912.
3
Combined treatment of the Walker tumour with radiotherapy and ICRF 159.沃克肿瘤的放射治疗与ICRF 159联合治疗
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974;82(4):329-34. doi: 10.1007/BF00285567.
本文引用的文献
1
Effect of ICRF159 on the mammalian cell cycle: significance for its use in cancer chemotherapy.ICRF159对哺乳动物细胞周期的影响：其在癌症化疗中的应用意义。
J Natl Cancer Inst. 1970 Mar;44(3):539-43.
2
Antitumour activity in a series of bisdiketopiperazines.一系列双二酮哌嗪的抗肿瘤活性。
Nature. 1969 Apr 26;222(5191):384-5. doi: 10.1038/222384a0.
3
Inhibition of metastatic spread by I.C.R.F. 159: selective deletion of a malignant characteristic.I.C.R.F. 159对转移扩散的抑制作用：恶性特征的选择性消除
Br Med J. 1970 Nov 7;4(5731):344-6. doi: 10.1136/bmj.4.5731.344.
4
Mode of action of the cytostatic agent "ICRF 159".细胞生长抑制剂“ICRF 159”的作用方式。
Nature. 1970 May 9;226(5245):524-6. doi: 10.1038/226524a0.
5
Control of malignant metastases by ICRF l59.
Nature. 1969 Oct 18;224(5216):273-5. doi: 10.1038/224273a0.
6
Preliminary clinical assessment of I.C.R.F. 159 in acute leukaemia and lymphosarcoma.I.C.R.F. 159用于急性白血病和淋巴肉瘤的初步临床评估。
Br Med J. 1969 Mar 29;1(5647):822-4. doi: 10.1136/bmj.1.5647.822.
7
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.人类恶性黑色素瘤中的肿瘤特异性抗体及其与疾病程度的关系。
Br Med J. 1969 Sep 6;3(5670):547-52. doi: 10.1136/bmj.3.5670.547.
Zotero 插件